Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Total Revenue

Arbutus Biopharma Cp Total Revenue Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Total Revenue from 2010 to 2018. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
  • Arbutus Biopharma Cp Total Revenue for the last 12 months ending December 12, 2018 was $6m a -101.71% decrease of -6m year over year
  • Arbutus Biopharma Cp Annual Total Revenue for 2018 was $6m a -81.36% decrease of -5m from 2017
  • Arbutus Biopharma Cp Annual Total Revenue for 2017 was $11m a 86.07% increase of 9m from 2016
  • Arbutus Biopharma Cp Annual Total Revenue for 2016 was $1m a -1,461.10% decrease of -22m from 2015
Other Income Statement Metrics:
  • Arbutus Biopharma Cp EBITDA for the quarter ending December 12, 2018 was $-15m a -5.44% increase of 1m year over year
  • Arbutus Biopharma Cp Net Income for the quarter ending December 12, 2018 was $-18m a 4.70% decrease of -1m year over year
View Chart On Koyfin

Quarterly ABUS Total Revenue Data

12/2018$2m
09/2018$2m
06/2018$1m
03/2018$1m
12/2017$3m
09/2017$7m
06/2017$1m
03/2017$0m
12/2016$0m
09/2016$1m

Annual ABUS Total Revenue Data

2018$6m
2017$11m
2016$1m
2015$23m
2014$15m
2013$15m
2012$14m
2011$17m
2010$21m
2009$14m